Active Ingredient History

  • Now
Pirarubicin (INN) is an anthracycline drug. An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent is less cardiotoxic than doxorubicin and exhibits activity against some doxorubicin-resistant cell lines.   Wikipedia

  • SMILES: COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O[C@H]6CCCCO6)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO
  • Mol. Mass: 627.64
  • ALogP: 1.55
  • ChEMBL Molecule:
More Chemistry
4'-o-tetrahydropyranyladriamycin | 4'-o-tetrahydropyranyldoxorubicin | 4'-o-tetrapyranyldoxorubicin | 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-4-o-(tetrahydro-2h-pyran-2-yl)-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- | adriamycin, tetrahydropyranyl | aventis brand of pirarubicin | pinorubicin | pirarubicin | pirarubicin hydrochloride | thepirubicin | theprubicin | théprubicine | therarubicin | thp-adm | thp-adriamycin | thp-dox | thp-doxorubicin


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue